Tag: Crohn’s Disease treatment
Hope Beyond Medications: New Nerve Therapy Shows Promise for IBD
A new nerve stimulation therapy for IBD is showing promise in early trials, offering hope for treatment that works with your body’s natural systems rather than suppressing your immune system. This innovative approach could represent a significant shift away from traditional medication-heavy treatment plans.
IBD ER Visits Drop 50% in 3 Years: A Sign of Real Progress
New data shows IBD emergency room visits have dropped by 50% in just three years, offering hope and evidence that better disease management is becoming a reality for our community. This significant improvement suggests we’re making real progress in reducing crisis moments and improving quality of life.
New China Restrictions Could Delay Breakthrough IBD Treatments
New U.S. restrictions on Chinese-developed medications could significantly delay breakthrough IBD treatments reaching American patients. Here’s what this policy debate means for our community and how to stay informed about potential impacts on treatment access.
Larry Nance Jr.’s Inspiring Journey: Turning Crohn’s Into NBA Success
NBA player Larry Nance Jr.’s journey from a devastating Crohn’s diagnosis at sixteen to professional basketball success offers hope and inspiration for anyone in the IBD community pursuing their dreams. His story proves that with the right support and determination, chronic illness doesn’t have to limit your ambitions.
Transform Doctor Visits: Your IBD Appointment Prep Guide
Doctor appointments can feel overwhelming when you’re managing IBD, but simple preparation strategies can transform these visits into empowering conversations. Learn how tracking symptoms, preparing questions, and advocating for yourself can improve your care and reduce appointment anxiety.
A Surgeon’s Gift: Hope for Fewer Operations for IBD Patients
Dr. Fabrizio Michelassi’s recognition for his groundbreaking strictureplasty technique offers hope for IBD patients facing surgery. His bowel preservation approach could mean fewer resections and better quality of life for those with Crohn’s disease.
New IBD Drug Shows Promise for Crohn’s and UC Patients
New clinical trial results for duvakitug show promising effectiveness for both Crohn’s disease and ulcerative colitis, offering hope for patients seeking better treatment options. This novel drug targets inflammation and scarring through a different mechanism than existing treatments, potentially expanding the toolkit for IBD management.
New Crohn’s Treatment Shows Promise for Real Healing
AstraZeneca’s new experimental drug AZD7798 takes a precision approach to Crohn’s treatment, targeting specific immune cells while aiming for actual intestinal healing rather than just symptom management. This targeted therapy could represent a significant shift toward treatments that address root causes and offer more stable, long-term remission.
Why Women with IBD Need Their Own Healthcare Champions
Women with IBD face unique challenges that deserve specialized medical attention and support. A new conference at Cedars-Sinai highlights the growing recognition that gender-specific IBD care is essential for optimal outcomes.
Scientists Find the ‘Master Switch’ Behind Crohn’s Inflammation
Scientists at Osaka University have identified two proteins that act as ‘master switches’ controlling chronic inflammation in Crohn’s disease. This breakthrough could lead to more targeted treatments that address root causes rather than just managing symptoms.
